Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) just unveiled an announcement.
Imricor Medical Systems, Inc. announced the application for the quotation of 344,900 new securities on the Australian Securities Exchange (ASX), with an issue date of September 6, 2025. This move is part of the company’s strategy to enhance its market presence and potentially increase its capital for further development and expansion, reflecting a significant step in its growth trajectory and offering potential implications for investors and stakeholders.
The most recent analyst rating on (AU:IMR) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. operates in the medical technology industry, focusing on the development and commercialization of MRI-compatible products. The company’s primary products are designed for use in cardiac procedures, with a focus on improving the safety and efficacy of MRI-guided interventions.
Average Trading Volume: 334,883
Technical Sentiment Signal: Buy
For an in-depth examination of IMR stock, go to TipRanks’ Overview page.